Portfolio Holdings Detail for ISIN IE00BL3J3G74
Stock Name / Fund iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CSPXx(MXN) CXE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Core S&P 500 UCITS ETF MXN Hedged (Acc) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-02 (Tuesday)	241,147	USD 178,931,074	USD 178,931,074	140	USD -1,850,687	USD 742	USD 750.11
2025-12-01 (Monday)	241,007	USD 180,781,761	USD 180,781,761	98	USD -7,173,032	USD 750.11	USD 780.19
2025-11-28 (Friday)	240,909	USD 187,954,793	USD 187,954,793	14	USD -1,053,833	USD 780.19	USD 784.61
2025-11-27 (Thursday)	240,895	USD 189,008,626	USD 189,008,626	0	USD 0	USD 784.61	USD 784.61
2025-11-26 (Wednesday)	240,895	USD 189,008,626	USD 189,008,626	14	USD -641,803	USD 784.61	USD 787.32
2025-11-25 (Tuesday)	240,881	USD 189,650,429	USD 189,650,429	-238	USD 6,050,366	USD 787.32	USD 761.45
2025-11-24 (Monday)	241,119	USD 183,600,063	USD 183,600,063	-504	USD 957,237	USD 761.45	USD 755.9
2025-11-21 (Friday)	241,623	USD 182,642,826	USD 182,642,826	-252	USD 4,380,951	USD 755.9	USD 737
2025-11-20 (Thursday)	241,875	USD 178,261,875	USD 178,261,875	-294	USD 8,077,610	USD 737	USD 702.75
2025-11-19 (Wednesday)	242,169	USD 170,184,265	USD 170,184,265	-140	USD -5,572,145	USD 702.75	USD 725.34
2025-11-18 (Tuesday)	242,309	USD 175,756,410	USD 175,756,410	-448	USD 4,780,227	USD 725.34	USD 704.31
2025-11-17 (Monday)	242,757	USD 170,976,183	USD 170,976,183	-28	USD 2,604,785	USD 704.31	USD 693.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BL3J3G74

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 140 742.000* 649.89
2025-12-01 BUY 98 779.840 748.210 751.373 USD 73,635 649.43
2025-11-28 BUY 14 780.190* 648.84
2025-11-26 BUY 14 790.980 777.000 778.398 USD 10,898 647.58
2025-11-26 BUY 14 790.980 777.000 778.398 USD 10,898 647.58
2025-11-25 SELL -238 790.570 760.700 763.687 USD -181,758 646.94 Loss of -27,786 on sale
2025-11-24 SELL -504 773.130 756.640 758.289 USD -382,178 646.41 Loss of -56,389 on sale
2025-11-21 SELL -252 755.900* 645.89 Profit of 162,765 on sale
2025-11-20 SELL -294 737.000* 645.47 Profit of 189,767 on sale
2025-11-19 SELL -140 702.750* 645.20 Profit of 90,327 on sale
2025-11-18 SELL -448 725.340* 644.82 Profit of 288,878 on sale
2025-11-17 SELL -28 711.880 692.290 694.249 USD -19,439 644.53 Loss of -1,392 on sale
2025-11-14 SELL -98 699.270 686.000 687.327 USD -67,358 644.30 Loss of -4,217 on sale
2025-11-13 SELL -112 713.580 679.930 683.295 USD -76,529 644.05 Loss of -4,395 on sale
2025-11-10 BUY 112 665.990 653.190 654.470 USD 73,301 643.67
2025-11-06 SELL -70 657.000 641.260 642.834 USD -44,998 643.59 Profit of 53 on sale
2025-11-05 SELL -42 646.895 628.000 629.890 USD -26,455 643.58 Profit of 575 on sale
2025-11-04 SELL -175 646.221 625.140 627.248 USD -109,768 643.66 Profit of 2,872 on sale
2025-10-31 SELL -28 659.760 645.000 646.476 USD -18,101 643.63 Loss of -80 on sale
2025-10-30 BUY 98 664.000 645.000 646.900 USD 63,396 643.57
2025-10-29 BUY 98 652.910 659.980 659.273 USD 64,609 643.53
2025-10-28 BUY 420 654.480 655.700 655.578 USD 275,343 643.47
2025-10-27 BUY 224 585.310 586.150 586.066 USD 131,279 643.77
2025-10-24 BUY 28 577.950 582.700 582.225 USD 16,302 644.11
2025-10-23 SELL -56 575.690 584.000 583.169 USD -32,657 644.46 Profit of 3,432 on sale
2025-10-22 BUY 112 584.740 588.710 588.313 USD 65,891 644.77
2025-10-21 BUY 42 579.340 582.410 582.103 USD 24,448 645.12
2025-10-17 BUY 210 578.050 579.040 578.941 USD 121,578 645.83
2025-10-16 BUY 14 569.170 589.080 587.089 USD 8,219 646.24
2025-10-14 SELL -84 572.600 576.180 575.822 USD -48,369 647.01 Profit of 5,980 on sale
2025-10-10 SELL -14 564.630 577.170 575.916 USD -8,063 647.46 Profit of 1,002 on sale
2025-10-08 BUY 112 563.860 605.000 600.886 USD 67,299 647.91
2025-10-07 BUY 420 583.240 591.450 590.629 USD 248,064 648.27
2025-10-06 BUY 14 585.480 603.650 601.833 USD 8,426 648.61
2025-10-03 BUY 196 600.000 618.010 616.209 USD 120,777 648.88
2025-10-02 BUY 154 600.000 605.410 604.869 USD 93,150 649.15
2025-10-01 BUY 98 599.940 615.390 613.845 USD 60,157 649.43
2025-09-30 BUY 140 562.270 574.040 572.863 USD 80,201 649.91
2025-09-29 BUY 126 560.750 564.910 564.494 USD 71,126 650.42
2025-09-26 BUY 154 563.900 564.610 564.539 USD 86,939 650.91
2025-09-25 BUY 196 555.510 579.000 576.651 USD 113,024 651.46
2025-09-18 BUY 14 598.710 600.000 599.871 USD 8,398 651.76
2025-09-17 BUY 126 585.500 587.670 587.453 USD 74,019 652.14
2025-09-11 BUY 70 568.200 570.760 570.504 USD 39,935 652.63
2025-09-09 BUY 70 556.530 563.570 562.866 USD 39,401 653.76
2025-07-31 SELL -2,214 545.460 558.130 556.863 USD -1,232,895 654.41 Profit of 215,958 on sale
2025-07-30 BUY 112 554.580 563.590 562.689 USD 63,021 655.00
2025-07-29 BUY 14 558.150 559.610 559.464 USD 7,832 655.58
2025-07-24 BUY 14 564.640 577.730 576.421 USD 8,070 656.13
2025-07-23 BUY 84 572.390 576.700 576.269 USD 48,407 656.63
2025-07-22 BUY 126 560.930 563.000 562.793 USD 70,912 657.22
2025-07-21 BUY 28 545.530 552.980 552.235 USD 15,463 657.90
2025-07-18 SELL -141 542.520 550.890 550.053 USD -77,557 658.62 Profit of 15,307 on sale
2025-07-17 BUY 14 550.000 554.480 554.032 USD 7,756 659.29
2025-07-16 BUY 56 547.930 558.350 557.308 USD 31,209 659.99
2025-07-15 SELL -225 547.960 574.750 572.071 USD -128,716 660.69 Profit of 19,939 on sale
2025-07-14 BUY 112 570.590 575.130 574.676 USD 64,364 661.26
2025-07-11 SELL -28 567.740 568.460 568.388 USD -15,915 661.86 Profit of 2,617 on sale
2025-07-10 BUY 112 559.760 566.370 565.709 USD 63,359 662.51
2025-07-09 BUY 112 552.580 558.380 557.800 USD 62,474 663.22
2025-07-08 BUY 86 547.750 559.460 558.289 USD 48,013 663.97
2025-07-07 SELL -322 538.110 547.590 546.642 USD -176,019 664.79 Profit of 38,045 on sale
2025-07-02 SELL -406 547.740 551.500 551.124 USD -223,756 667.14 Profit of 47,102 on sale
2025-06-30 BUY 238 525.000 526.080 525.972 USD 125,181 668.09
2025-06-27 BUY 126 521.000 531.210 530.189 USD 66,804 669.09
2025-06-25 SELL -28 520.290 525.630 525.096 USD -14,703 671.12 Profit of 4,089 on sale
2025-06-24 BUY 18 522.270 527.450 526.932 USD 9,485 672.15
2025-06-23 BUY 364 511.920 516.180 515.754 USD 187,734 673.26
2025-06-18 SELL -84 513.580 519.170 518.611 USD -43,563 675.51 Profit of 13,179 on sale
2025-06-13 SELL -42 529.240 529.550 529.519 USD -22,240 678.86 Profit of 6,272 on sale
2025-06-12 BUY 42 521.840 525.220 524.882 USD 22,045 680.00
2025-06-11 BUY 56 518.600 528.370 527.393 USD 29,534 681.17
2025-06-06 SELL -70 493.220 499.880 499.214 USD -34,945 684.97 Profit of 13,003 on sale
2025-06-05 SELL -42 483.070 491.770 490.900 USD -20,618 686.49 Profit of 8,215 on sale
2025-06-04 SELL -56 484.930 499.900 498.403 USD -27,911 688.02 Profit of 10,619 on sale
2025-06-02 BUY 182 490.810 502.560 501.385 USD 91,252 691.08
2025-05-30 SELL -42 490.280 519.780 516.830 USD -21,707 692.63 Profit of 7,384 on sale
2025-05-29 BUY 14 605.390 605.730 605.696 USD 8,480 693.31
2025-05-28 SELL -14 591.850 606.000 604.585 USD -8,464 694.11 Profit of 1,253 on sale
2025-05-27 BUY 154 603.260 608.170 607.679 USD 93,583 694.83
2025-05-23 SELL -280 588.340 591.640 591.310 USD -165,567 696.55 Profit of 29,468 on sale
2025-05-22 SELL -308 596.850 605.500 604.635 USD -186,228 697.36 Profit of 28,560 on sale
2025-05-21 BUY 14 604.620 617.520 616.230 USD 8,627 698.12
2025-05-20 BUY 112 614.790 615.450 615.384 USD 68,923 698.81
2025-05-19 BUY 406 596.540 598.560 598.358 USD 242,933 699.66
2025-05-16 BUY 378 594.320 595.190 595.103 USD 224,949 700.55
2025-05-15 BUY 308 584.990 585.260 585.233 USD 180,252 701.53
2025-05-14 BUY 280 571.360 580.560 579.640 USD 162,299 702.64
2025-05-13 SELL -56 574.160 575.050 574.961 USD -32,198 703.75 Profit of 7,212 on sale
2025-05-12 BUY 14 575.630 577.990 577.754 USD 8,089 704.86
2025-05-09 BUY 42 527.780 552.840 550.334 USD 23,114 706.42
2025-05-08 SELL -406 547.670 552.570 552.080 USD -224,144 707.82 Profit of 63,231 on sale
2025-05-07 SELL -196 560.930 568.130 567.410 USD -111,212 709.13 Profit of 27,778 on sale
2025-05-06 BUY 490 558.520 606.870 602.035 USD 294,997 710.49
2025-05-02 BUY 42 605.610 615.610 614.610 USD 25,814 712.43
2025-05-01 SELL -70 590.000 593.930 593.537 USD -41,548 713.57 Profit of 8,402 on sale
2025-04-30 BUY 42 598.760 600.200 600.056 USD 25,202 714.64
2025-04-29 BUY 98 568.910 579.980 578.873 USD 56,730 716.01
2025-04-28 BUY 223 610.860 614.830 614.433 USD 137,019 717.02
2025-04-25 BUY 210 602.640 602.790 602.775 USD 126,583 718.12
2025-04-24 BUY 60 599.760 601.280 601.128 USD 36,068 719.26
2025-04-23 BUY 165 587.850 603.770 602.178 USD 99,359 720.55
2025-04-22 SELL -92 585.490 587.100 586.939 USD -53,998 721.89 Profit of 12,415 on sale
2025-04-17 BUY 30 563.160 564.210 564.105 USD 16,923 725.10
2025-04-16 BUY 1,002 549.280 561.830 560.575 USD 561,696 726.89
2025-04-15 BUY 280 557.910 575.200 573.471 USD 160,572 728.63
2025-04-11 BUY 350 554.180 555.530 555.395 USD 194,388 732.13
2025-04-10 BUY 574 546.390 571.990 569.430 USD 326,853 734.10
2025-04-09 BUY 112 576.720 580.730 580.329 USD 64,997 735.80
2025-04-08 BUY 294 556.810 586.030 583.108 USD 171,434 737.74
2025-04-07 BUY 336 572.780 591.540 589.664 USD 198,127 739.55
2025-04-04 SELL -840 573.450 612.990 609.036 USD -511,590 741.40 Profit of 111,185 on sale
2025-04-02 BUY 98 625.600 628.000 627.760 USD 61,520 742.70
2025-03-31 SELL -378 634.230 640.720 640.071 USD -241,947 745.39 Profit of 39,812 on sale
2025-03-28 SELL -238 637.360 642.970 642.409 USD -152,893 746.65 Profit of 24,809 on sale
2025-03-27 SELL -70 635.830 643.430 642.670 USD -44,987 747.95 Profit of 7,370 on sale
2025-03-26 BUY 126 640.140 644.000 643.614 USD 81,095 749.24
2025-03-25 SELL -168 634.140 662.570 659.727 USD -110,834 750.62 Profit of 15,270 on sale
2025-03-24 BUY 98 661.000 667.460 666.814 USD 65,348 751.72
2025-03-21 BUY 168 658.480 661.000 660.748 USD 111,006 752.87
2025-03-19 BUY 28 672.360 674.570 674.349 USD 18,882 755.03
2025-03-18 SELL -252 664.960 678.270 676.939 USD -170,589 756.18 Profit of 19,969 on sale
2025-03-17 BUY 266 678.420 679.830 679.689 USD 180,797 757.19
2025-03-14 BUY 238 666.870 686.980 684.969 USD 163,023 758.38
2025-03-13 BUY 1,176 680.610 698.950 697.116 USD 819,808 759.42
2025-03-12 BUY 560 689.500 712.460 710.164 USD 397,692 760.36
2025-03-11 BUY 224 718.160 747.700 744.746 USD 166,823 760.94
2025-03-07 BUY 134 707.510 729.750 727.526 USD 97,488 761.92
2025-03-06 SELL -126 698.440 701.000 700.744 USD -88,294 762.83 Profit of 7,822 on sale
2025-03-05 BUY 434 687.150 692.790 692.226 USD 300,426 763.92
2025-03-04 BUY 84 675.490 697.460 695.263 USD 58,402 765.22
2025-03-03 BUY 378 684.870 704.640 702.663 USD 265,607 766.42
2025-02-28 SELL -98 698.740 708.580 707.596 USD -69,344 767.45 Profit of 5,866 on sale
2025-02-27 BUY 14 702.780 721.000 719.178 USD 10,068 768.44
2025-02-26 SELL -28 706.940 721.410 719.963 USD -20,159 769.41 Profit of 1,384 on sale
2025-02-25 BUY 266 723.470 739.000 737.447 USD 196,161 770.13
2025-02-21 BUY 196 700.330 704.080 703.705 USD 137,926 772.21
2025-02-20 BUY 112 696.020 703.140 702.428 USD 78,672 773.48
2025-02-19 BUY 28 685.660 688.670 688.369 USD 19,274 774.97
2025-02-18 BUY 70 680.000 689.950 688.955 USD 48,227 776.61
2025-02-13 BUY 238 674.270 677.690 677.348 USD 161,209 782.21
2025-02-12 BUY 84 663.860 670.980 670.268 USD 56,303 784.41
2025-02-11 SELL -28 665.460 680.790 679.257 USD -19,019 786.65 Profit of 3,007 on sale
2025-02-07 SELL -112 710.000 731.420 729.278 USD -81,679 790.04 Profit of 6,805 on sale
2025-02-06 BUY 56 722.070 734.270 733.050 USD 41,051 791.40
2025-02-04 BUY 490 697.050 709.980 708.687 USD 347,257 794.92
2025-02-03 BUY 182 666.850 673.650 672.970 USD 122,481 797.65
2025-01-31 BUY 42 672.980 688.000 686.498 USD 28,833 800.36
2025-01-30 BUY 28 683.080 689.620 688.966 USD 19,291 802.96
2025-01-29 BUY 266 687.270 697.570 696.540 USD 185,280 805.59
2025-01-28 BUY 126 686.330 690.300 689.903 USD 86,928 808.37
2025-01-27 BUY 196 684.710 698.450 697.076 USD 136,627 811.31
2025-01-24 BUY 126 675.790 693.840 692.035 USD 87,196 814.61
2025-01-23 BUY 364 694.640 696.190 696.035 USD 253,357 817.61
2025-01-02 BUY 462 715.190 726.810 725.648 USD 335,249 820.24
2024-12-30 BUY 2,078 702.590 708.970 708.332 USD 1,471,914 823.34
2024-12-10 BUY 105 778.500 791.490 790.191 USD 82,970 824.55
2024-12-09 BUY 120 788.000 800.990 799.691 USD 95,963 825.56
2024-12-06 BUY 180 778.000 778.120 778.108 USD 140,059 826.92
2024-12-05 BUY 45 767.900 768.020 768.008 USD 34,560 828.66
2024-12-04 BUY 165 754.260 756.130 755.943 USD 124,731 830.91
2024-12-03 BUY 531 749.570 770.000 767.957 USD 407,785 833.46
2024-12-02 BUY 44 762.340 763.890 763.735 USD 33,604 835.75
2024-11-29 SELL -384 750.220 754.510 754.081 USD -289,567 838.60 Profit of 32,455 on sale
2024-11-27 BUY 405 754.870 762.160 761.431 USD 308,380 844.58
2024-11-26 BUY 870 753.030 754.180 754.065 USD 656,037 851.62
2024-11-26 BUY 870 753.030 754.180 754.065 USD 656,037 851.62
2024-11-25 BUY 900 749.510 757.860 757.025 USD 681,322 855.71
2024-11-22 BUY 1,050 738.000 751.400 750.060 USD 787,563 860.61
2024-11-21 BUY 165 744.500 757.560 756.254 USD 124,782 865.66
2024-11-20 BUY 150 743.350 750.690 749.956 USD 112,493 871.22
2024-11-19 BUY 135 744.600 758.600 757.200 USD 102,222 877.25
2024-11-18 BUY 1,215 762.000 762.700 762.630 USD 926,595 883.01
2024-11-12 BUY 420 821.000 831.000 830.000 USD 348,600 886.28
2024-11-11 BUY 285 825.680 834.420 833.546 USD 237,561 889.64
2024-11-08 BUY 218 828.420 830.730 830.499 USD 181,049 893.24
2024-11-07 BUY 1,335 824.480 832.530 831.725 USD 1,110,353 897.54
2024-11-06 BUY 1,106 816.650 844.510 841.724 USD 930,947 902.93
2024-11-05 BUY 596 829.430 836.630 835.910 USD 498,202 914.24
2024-11-05 BUY 596 829.430 836.630 835.910 USD 498,202 914.24
2024-11-04 BUY 105 828.840 852.010 849.693 USD 89,218 921.36
2024-11-01 BUY 240 843.600 862.000 860.160 USD 206,438 928.43
2024-10-31 BUY 60 838.200 883.150 878.655 USD 52,719 937.45
2024-10-30 BUY 149 922.790 935.860 934.553 USD 139,248 939.08
2024-10-29 BUY 555 927.330 932.380 931.875 USD 517,191 940.55
2024-10-28 SELL -105 928.610 943.270 941.804 USD -98,889 944.53 Profit of 286 on sale
2024-10-28 SELL -105 928.610 943.270 941.804 USD -98,889 944.53 Profit of 286 on sale
2024-10-25 BUY 180 933.020 943.830 942.749 USD 169,695 950.28
2024-10-25 BUY 180 933.020 943.830 942.749 USD 169,695 950.28
2024-10-24 BUY 120 928.900 952.020 949.708 USD 113,965 957.41
2024-10-23 BUY 150 941.390 959.600 957.779 USD 143,667 965.42
2024-10-22 BUY 807 962.340 972.750 971.709 USD 784,169 968.50
2024-10-21 BUY 420 968.500 991.240 988.966 USD 415,366 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	140			742.000*		649.89
2025-12-01	BUY	98	779.840	748.210	751.373	USD 73,635	649.43
2025-11-28	BUY	14			780.190*		648.84
2025-11-26	BUY	14	790.980	777.000	778.398	USD 10,898	647.58
2025-11-26	BUY	14	790.980	777.000	778.398	USD 10,898	647.58
2025-11-25	SELL	-238	790.570	760.700	763.687	USD -181,758	646.94 Loss of -27,786 on sale
2025-11-24	SELL	-504	773.130	756.640	758.289	USD -382,178	646.41 Loss of -56,389 on sale
2025-11-21	SELL	-252			755.900*		645.89 Profit of 162,765 on sale
2025-11-20	SELL	-294			737.000*		645.47 Profit of 189,767 on sale
2025-11-19	SELL	-140			702.750*		645.20 Profit of 90,327 on sale
2025-11-18	SELL	-448			725.340*		644.82 Profit of 288,878 on sale
2025-11-17	SELL	-28	711.880	692.290	694.249	USD -19,439	644.53 Loss of -1,392 on sale
2025-11-14	SELL	-98	699.270	686.000	687.327	USD -67,358	644.30 Loss of -4,217 on sale
2025-11-13	SELL	-112	713.580	679.930	683.295	USD -76,529	644.05 Loss of -4,395 on sale
2025-11-10	BUY	112	665.990	653.190	654.470	USD 73,301	643.67
2025-11-06	SELL	-70	657.000	641.260	642.834	USD -44,998	643.59 Profit of 53 on sale
2025-11-05	SELL	-42	646.895	628.000	629.890	USD -26,455	643.58 Profit of 575 on sale
2025-11-04	SELL	-175	646.221	625.140	627.248	USD -109,768	643.66 Profit of 2,872 on sale
2025-10-31	SELL	-28	659.760	645.000	646.476	USD -18,101	643.63 Loss of -80 on sale
2025-10-30	BUY	98	664.000	645.000	646.900	USD 63,396	643.57
2025-10-29	BUY	98	652.910	659.980	659.273	USD 64,609	643.53
2025-10-28	BUY	420	654.480	655.700	655.578	USD 275,343	643.47
2025-10-27	BUY	224	585.310	586.150	586.066	USD 131,279	643.77
2025-10-24	BUY	28	577.950	582.700	582.225	USD 16,302	644.11
2025-10-23	SELL	-56	575.690	584.000	583.169	USD -32,657	644.46 Profit of 3,432 on sale
2025-10-22	BUY	112	584.740	588.710	588.313	USD 65,891	644.77
2025-10-21	BUY	42	579.340	582.410	582.103	USD 24,448	645.12
2025-10-17	BUY	210	578.050	579.040	578.941	USD 121,578	645.83
2025-10-16	BUY	14	569.170	589.080	587.089	USD 8,219	646.24
2025-10-14	SELL	-84	572.600	576.180	575.822	USD -48,369	647.01 Profit of 5,980 on sale
2025-10-10	SELL	-14	564.630	577.170	575.916	USD -8,063	647.46 Profit of 1,002 on sale
2025-10-08	BUY	112	563.860	605.000	600.886	USD 67,299	647.91
2025-10-07	BUY	420	583.240	591.450	590.629	USD 248,064	648.27
2025-10-06	BUY	14	585.480	603.650	601.833	USD 8,426	648.61
2025-10-03	BUY	196	600.000	618.010	616.209	USD 120,777	648.88
2025-10-02	BUY	154	600.000	605.410	604.869	USD 93,150	649.15
2025-10-01	BUY	98	599.940	615.390	613.845	USD 60,157	649.43
2025-09-30	BUY	140	562.270	574.040	572.863	USD 80,201	649.91
2025-09-29	BUY	126	560.750	564.910	564.494	USD 71,126	650.42
2025-09-26	BUY	154	563.900	564.610	564.539	USD 86,939	650.91
2025-09-25	BUY	196	555.510	579.000	576.651	USD 113,024	651.46
2025-09-18	BUY	14	598.710	600.000	599.871	USD 8,398	651.76
2025-09-17	BUY	126	585.500	587.670	587.453	USD 74,019	652.14
2025-09-11	BUY	70	568.200	570.760	570.504	USD 39,935	652.63
2025-09-09	BUY	70	556.530	563.570	562.866	USD 39,401	653.76
2025-07-31	SELL	-2,214	545.460	558.130	556.863	USD -1,232,895	654.41 Profit of 215,958 on sale
2025-07-30	BUY	112	554.580	563.590	562.689	USD 63,021	655.00
2025-07-29	BUY	14	558.150	559.610	559.464	USD 7,832	655.58
2025-07-24	BUY	14	564.640	577.730	576.421	USD 8,070	656.13
2025-07-23	BUY	84	572.390	576.700	576.269	USD 48,407	656.63
2025-07-22	BUY	126	560.930	563.000	562.793	USD 70,912	657.22
2025-07-21	BUY	28	545.530	552.980	552.235	USD 15,463	657.90
2025-07-18	SELL	-141	542.520	550.890	550.053	USD -77,557	658.62 Profit of 15,307 on sale
2025-07-17	BUY	14	550.000	554.480	554.032	USD 7,756	659.29
2025-07-16	BUY	56	547.930	558.350	557.308	USD 31,209	659.99
2025-07-15	SELL	-225	547.960	574.750	572.071	USD -128,716	660.69 Profit of 19,939 on sale
2025-07-14	BUY	112	570.590	575.130	574.676	USD 64,364	661.26
2025-07-11	SELL	-28	567.740	568.460	568.388	USD -15,915	661.86 Profit of 2,617 on sale
2025-07-10	BUY	112	559.760	566.370	565.709	USD 63,359	662.51
2025-07-09	BUY	112	552.580	558.380	557.800	USD 62,474	663.22
2025-07-08	BUY	86	547.750	559.460	558.289	USD 48,013	663.97
2025-07-07	SELL	-322	538.110	547.590	546.642	USD -176,019	664.79 Profit of 38,045 on sale
2025-07-02	SELL	-406	547.740	551.500	551.124	USD -223,756	667.14 Profit of 47,102 on sale
2025-06-30	BUY	238	525.000	526.080	525.972	USD 125,181	668.09
2025-06-27	BUY	126	521.000	531.210	530.189	USD 66,804	669.09
2025-06-25	SELL	-28	520.290	525.630	525.096	USD -14,703	671.12 Profit of 4,089 on sale
2025-06-24	BUY	18	522.270	527.450	526.932	USD 9,485	672.15
2025-06-23	BUY	364	511.920	516.180	515.754	USD 187,734	673.26
2025-06-18	SELL	-84	513.580	519.170	518.611	USD -43,563	675.51 Profit of 13,179 on sale
2025-06-13	SELL	-42	529.240	529.550	529.519	USD -22,240	678.86 Profit of 6,272 on sale
2025-06-12	BUY	42	521.840	525.220	524.882	USD 22,045	680.00
2025-06-11	BUY	56	518.600	528.370	527.393	USD 29,534	681.17
2025-06-06	SELL	-70	493.220	499.880	499.214	USD -34,945	684.97 Profit of 13,003 on sale
2025-06-05	SELL	-42	483.070	491.770	490.900	USD -20,618	686.49 Profit of 8,215 on sale
2025-06-04	SELL	-56	484.930	499.900	498.403	USD -27,911	688.02 Profit of 10,619 on sale
2025-06-02	BUY	182	490.810	502.560	501.385	USD 91,252	691.08
2025-05-30	SELL	-42	490.280	519.780	516.830	USD -21,707	692.63 Profit of 7,384 on sale
2025-05-29	BUY	14	605.390	605.730	605.696	USD 8,480	693.31
2025-05-28	SELL	-14	591.850	606.000	604.585	USD -8,464	694.11 Profit of 1,253 on sale
2025-05-27	BUY	154	603.260	608.170	607.679	USD 93,583	694.83
2025-05-23	SELL	-280	588.340	591.640	591.310	USD -165,567	696.55 Profit of 29,468 on sale
2025-05-22	SELL	-308	596.850	605.500	604.635	USD -186,228	697.36 Profit of 28,560 on sale
2025-05-21	BUY	14	604.620	617.520	616.230	USD 8,627	698.12
2025-05-20	BUY	112	614.790	615.450	615.384	USD 68,923	698.81
2025-05-19	BUY	406	596.540	598.560	598.358	USD 242,933	699.66
2025-05-16	BUY	378	594.320	595.190	595.103	USD 224,949	700.55
2025-05-15	BUY	308	584.990	585.260	585.233	USD 180,252	701.53
2025-05-14	BUY	280	571.360	580.560	579.640	USD 162,299	702.64
2025-05-13	SELL	-56	574.160	575.050	574.961	USD -32,198	703.75 Profit of 7,212 on sale
2025-05-12	BUY	14	575.630	577.990	577.754	USD 8,089	704.86
2025-05-09	BUY	42	527.780	552.840	550.334	USD 23,114	706.42
2025-05-08	SELL	-406	547.670	552.570	552.080	USD -224,144	707.82 Profit of 63,231 on sale
2025-05-07	SELL	-196	560.930	568.130	567.410	USD -111,212	709.13 Profit of 27,778 on sale
2025-05-06	BUY	490	558.520	606.870	602.035	USD 294,997	710.49
2025-05-02	BUY	42	605.610	615.610	614.610	USD 25,814	712.43
2025-05-01	SELL	-70	590.000	593.930	593.537	USD -41,548	713.57 Profit of 8,402 on sale
2025-04-30	BUY	42	598.760	600.200	600.056	USD 25,202	714.64
2025-04-29	BUY	98	568.910	579.980	578.873	USD 56,730	716.01
2025-04-28	BUY	223	610.860	614.830	614.433	USD 137,019	717.02
2025-04-25	BUY	210	602.640	602.790	602.775	USD 126,583	718.12
2025-04-24	BUY	60	599.760	601.280	601.128	USD 36,068	719.26
2025-04-23	BUY	165	587.850	603.770	602.178	USD 99,359	720.55
2025-04-22	SELL	-92	585.490	587.100	586.939	USD -53,998	721.89 Profit of 12,415 on sale
2025-04-17	BUY	30	563.160	564.210	564.105	USD 16,923	725.10
2025-04-16	BUY	1,002	549.280	561.830	560.575	USD 561,696	726.89
2025-04-15	BUY	280	557.910	575.200	573.471	USD 160,572	728.63
2025-04-11	BUY	350	554.180	555.530	555.395	USD 194,388	732.13
2025-04-10	BUY	574	546.390	571.990	569.430	USD 326,853	734.10
2025-04-09	BUY	112	576.720	580.730	580.329	USD 64,997	735.80
2025-04-08	BUY	294	556.810	586.030	583.108	USD 171,434	737.74
2025-04-07	BUY	336	572.780	591.540	589.664	USD 198,127	739.55
2025-04-04	SELL	-840	573.450	612.990	609.036	USD -511,590	741.40 Profit of 111,185 on sale
2025-04-02	BUY	98	625.600	628.000	627.760	USD 61,520	742.70
2025-03-31	SELL	-378	634.230	640.720	640.071	USD -241,947	745.39 Profit of 39,812 on sale
2025-03-28	SELL	-238	637.360	642.970	642.409	USD -152,893	746.65 Profit of 24,809 on sale
2025-03-27	SELL	-70	635.830	643.430	642.670	USD -44,987	747.95 Profit of 7,370 on sale
2025-03-26	BUY	126	640.140	644.000	643.614	USD 81,095	749.24
2025-03-25	SELL	-168	634.140	662.570	659.727	USD -110,834	750.62 Profit of 15,270 on sale
2025-03-24	BUY	98	661.000	667.460	666.814	USD 65,348	751.72
2025-03-21	BUY	168	658.480	661.000	660.748	USD 111,006	752.87
2025-03-19	BUY	28	672.360	674.570	674.349	USD 18,882	755.03
2025-03-18	SELL	-252	664.960	678.270	676.939	USD -170,589	756.18 Profit of 19,969 on sale
2025-03-17	BUY	266	678.420	679.830	679.689	USD 180,797	757.19
2025-03-14	BUY	238	666.870	686.980	684.969	USD 163,023	758.38
2025-03-13	BUY	1,176	680.610	698.950	697.116	USD 819,808	759.42
2025-03-12	BUY	560	689.500	712.460	710.164	USD 397,692	760.36
2025-03-11	BUY	224	718.160	747.700	744.746	USD 166,823	760.94
2025-03-07	BUY	134	707.510	729.750	727.526	USD 97,488	761.92
2025-03-06	SELL	-126	698.440	701.000	700.744	USD -88,294	762.83 Profit of 7,822 on sale
2025-03-05	BUY	434	687.150	692.790	692.226	USD 300,426	763.92
2025-03-04	BUY	84	675.490	697.460	695.263	USD 58,402	765.22
2025-03-03	BUY	378	684.870	704.640	702.663	USD 265,607	766.42
2025-02-28	SELL	-98	698.740	708.580	707.596	USD -69,344	767.45 Profit of 5,866 on sale
2025-02-27	BUY	14	702.780	721.000	719.178	USD 10,068	768.44
2025-02-26	SELL	-28	706.940	721.410	719.963	USD -20,159	769.41 Profit of 1,384 on sale
2025-02-25	BUY	266	723.470	739.000	737.447	USD 196,161	770.13
2025-02-21	BUY	196	700.330	704.080	703.705	USD 137,926	772.21
2025-02-20	BUY	112	696.020	703.140	702.428	USD 78,672	773.48
2025-02-19	BUY	28	685.660	688.670	688.369	USD 19,274	774.97
2025-02-18	BUY	70	680.000	689.950	688.955	USD 48,227	776.61
2025-02-13	BUY	238	674.270	677.690	677.348	USD 161,209	782.21
2025-02-12	BUY	84	663.860	670.980	670.268	USD 56,303	784.41
2025-02-11	SELL	-28	665.460	680.790	679.257	USD -19,019	786.65 Profit of 3,007 on sale
2025-02-07	SELL	-112	710.000	731.420	729.278	USD -81,679	790.04 Profit of 6,805 on sale
2025-02-06	BUY	56	722.070	734.270	733.050	USD 41,051	791.40
2025-02-04	BUY	490	697.050	709.980	708.687	USD 347,257	794.92
2025-02-03	BUY	182	666.850	673.650	672.970	USD 122,481	797.65
2025-01-31	BUY	42	672.980	688.000	686.498	USD 28,833	800.36
2025-01-30	BUY	28	683.080	689.620	688.966	USD 19,291	802.96
2025-01-29	BUY	266	687.270	697.570	696.540	USD 185,280	805.59
2025-01-28	BUY	126	686.330	690.300	689.903	USD 86,928	808.37
2025-01-27	BUY	196	684.710	698.450	697.076	USD 136,627	811.31
2025-01-24	BUY	126	675.790	693.840	692.035	USD 87,196	814.61
2025-01-23	BUY	364	694.640	696.190	696.035	USD 253,357	817.61
2025-01-02	BUY	462	715.190	726.810	725.648	USD 335,249	820.24
2024-12-30	BUY	2,078	702.590	708.970	708.332	USD 1,471,914	823.34
2024-12-10	BUY	105	778.500	791.490	790.191	USD 82,970	824.55
2024-12-09	BUY	120	788.000	800.990	799.691	USD 95,963	825.56
2024-12-06	BUY	180	778.000	778.120	778.108	USD 140,059	826.92
2024-12-05	BUY	45	767.900	768.020	768.008	USD 34,560	828.66
2024-12-04	BUY	165	754.260	756.130	755.943	USD 124,731	830.91
2024-12-03	BUY	531	749.570	770.000	767.957	USD 407,785	833.46
2024-12-02	BUY	44	762.340	763.890	763.735	USD 33,604	835.75
2024-11-29	SELL	-384	750.220	754.510	754.081	USD -289,567	838.60 Profit of 32,455 on sale
2024-11-27	BUY	405	754.870	762.160	761.431	USD 308,380	844.58
2024-11-26	BUY	870	753.030	754.180	754.065	USD 656,037	851.62
2024-11-26	BUY	870	753.030	754.180	754.065	USD 656,037	851.62
2024-11-25	BUY	900	749.510	757.860	757.025	USD 681,322	855.71
2024-11-22	BUY	1,050	738.000	751.400	750.060	USD 787,563	860.61
2024-11-21	BUY	165	744.500	757.560	756.254	USD 124,782	865.66
2024-11-20	BUY	150	743.350	750.690	749.956	USD 112,493	871.22
2024-11-19	BUY	135	744.600	758.600	757.200	USD 102,222	877.25
2024-11-18	BUY	1,215	762.000	762.700	762.630	USD 926,595	883.01
2024-11-12	BUY	420	821.000	831.000	830.000	USD 348,600	886.28
2024-11-11	BUY	285	825.680	834.420	833.546	USD 237,561	889.64
2024-11-08	BUY	218	828.420	830.730	830.499	USD 181,049	893.24
2024-11-07	BUY	1,335	824.480	832.530	831.725	USD 1,110,353	897.54
2024-11-06	BUY	1,106	816.650	844.510	841.724	USD 930,947	902.93
2024-11-05	BUY	596	829.430	836.630	835.910	USD 498,202	914.24
2024-11-05	BUY	596	829.430	836.630	835.910	USD 498,202	914.24
2024-11-04	BUY	105	828.840	852.010	849.693	USD 89,218	921.36
2024-11-01	BUY	240	843.600	862.000	860.160	USD 206,438	928.43
2024-10-31	BUY	60	838.200	883.150	878.655	USD 52,719	937.45
2024-10-30	BUY	149	922.790	935.860	934.553	USD 139,248	939.08
2024-10-29	BUY	555	927.330	932.380	931.875	USD 517,191	940.55
2024-10-28	SELL	-105	928.610	943.270	941.804	USD -98,889	944.53 Profit of 286 on sale
2024-10-28	SELL	-105	928.610	943.270	941.804	USD -98,889	944.53 Profit of 286 on sale
2024-10-25	BUY	180	933.020	943.830	942.749	USD 169,695	950.28
2024-10-25	BUY	180	933.020	943.830	942.749	USD 169,695	950.28
2024-10-24	BUY	120	928.900	952.020	949.708	USD 113,965	957.41
2024-10-23	BUY	150	941.390	959.600	957.779	USD 143,667	965.42
2024-10-22	BUY	807	962.340	972.750	971.709	USD 784,169	968.50
2024-10-21	BUY	420	968.500	991.240	988.966	USD 415,366	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.